{{Rsnum
|rsid=17348202
|Chromosome=2
|position=221207458
|Orientation=plus
|GMAF=0.03306
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.0 | 11.5 | 88.5
| HCB | 0.0 | 0.7 | 99.3
| JPT | 0.0 | 0.0 | 100.0
| YRI | 0.0 | 3.4 | 96.6
| ASW | 0.0 | 3.5 | 96.5
| CHB | 0.0 | 0.7 | 99.3
| CHD | 0.0 | 0.0 | 0.0
| GIH | 1.0 | 18.8 | 80.2
| LWK | 0.0 | 1.8 | 98.2
| MEX | 0.0 | 12.1 | 87.9
| MKK | 0.0 | 4.5 | 95.5
| TSI | 0.0 | 19.6 | 80.4
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23776197
  |Trait=Paclitaxel-induced neuropathy
  |Title=Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy.
  |RiskAllele=G
  |Pval=1E-6
  |OR=4.85
  |ORtxt=[2.57-9.13]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}